{"id":"W2947312373","doi":"10.1093/annonc/mdz247.158","title":"Infigratinib versus gemcitabine plus cisplatin multicenter, open-label, randomized, phase III study in patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: The PROOF trial","year":2019,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Medicine; Gemcitabine; Open label; Cisplatin; Oncology; Internal medicine; Randomized controlled trial; Chromosomal translocation; Surgery; Chemotherapy; Gene; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008810854,0.0002370426,0.0006660848,0.0001139525,0.00007966618,0.00002694111,0.000596476,0.000134309,0.00004363513],"category_scores_gemma":[0.0002823218,0.000145928,0.00005514641,0.0002854984,0.0002249361,0.00002845339,0.0002374624,0.0002322223,0.000006153939],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002924915,"about_ca_system_score_gemma":0.000433234,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001379741,"about_ca_topic_score_gemma":0.0006851768,"domain_scores_codex":[0.9976184,0.000632975,0.0005633869,0.0004785336,0.0003284386,0.0003782198],"domain_scores_gemma":[0.9982598,0.0002820522,0.0003169824,0.0006167952,0.0004388182,0.00008559105],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9738689,0.005189425,0.005674683,0.00001913086,0.0003297184,0.000005186732,0.000599977,0.0001858885,0.009569426,0.00001360679,0.0001047797,0.004439272],"study_design_scores_gemma":[0.9309543,0.05464857,0.003849848,0.00003320488,0.00004982209,0.000001093916,0.0003954829,0.0001481806,0.009199522,0.000002876812,0.0005268573,0.0001902719],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9892038,0.00018144,0.00006222616,0.0003171986,0.000129571,0.009583415,0.00004047838,0.000005350431,0.0004765867],"genre_scores_gemma":[0.998188,0.00003646315,0.0005038622,0.0001126433,0.00004106956,0.0007486039,0.0002373114,0.00003035133,0.0001016933],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04945914,"threshold_uncertainty_score":0.5950773,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06011972269563243,"score_gpt":0.3937258460936424,"score_spread":0.33360612339801,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}